Custom Intellia Therapeutics: High-Quality Solutions with Thermo Fisher & Miltenyi
We are excited to announce our collaboration with T&L Biotechnology Co., Ltd. to develop custom CRISPR/Cas9-based therapeutics. Our partnership aims to leverage Intellia Therapeutics' cutting-edge gene editing technology and T&L Biotechnology's expertise in biopharmaceutical research to create personalized treatments for a range of genetic diseases, By combining Intellia Therapeutics' innovative approach to gene editing with T&L Biotechnology's commitment to advancing biopharmaceutical research, we are confident that our joint efforts will lead to the development of transformative therapies that have the potential to change the lives of patients worldwide, We are excited to embark on this journey with T&L Biotechnology Co., Ltd., and look forward to the promising advancements that our collaboration will bring to the field of precision medicine
